Journal of Urban Health

, Volume 82, Issue 2, pp 267–275 | Cite as

A description of a peer-run supervised injection site for injection drug users

  • Thomas Kerr
  • Megan Oleson
  • Mark W. Tyndall
  • Julio Montaner
  • Evan Wood


Owing to the ongoing health crisis among injection drug users in Vancouver, Canada, there have been repeated calls for the establishment of supervised injection sites (SIS) since the early 1990s. In April 2003, a group of advocates and drug users opened an unsanctioned SIS in Vancouver’s Downtown Eastside. The “327 SIS” operated for 184 days. During the operation of the SIS, volunteers supervised over 3,000 injections by a bigh-risk injection drug using population. The SIS provided a sterile environment for injection drug use without measured negative consequences and demonstrated the feasibility of a peer-driven low-threshold SIS.


Peer-driven Safer injection site Vancouver 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Des Jarlais DC, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995;274:1226–1231.PubMedCrossRefGoogle Scholar
  2. 2.
    Fischer B, Rehm J, Blitz-Miller T. Injection drug use and preventive measures: a comparison of Canadian and western European jurisdictions over time. CMAJ. 2000;162:1709–1713.PubMedCentralPubMedGoogle Scholar
  3. 3.
    Strathdee SA, Patrick DM, Currie SL, et al. Meedle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11:F59-F65.PubMedCrossRefGoogle Scholar
  4. 4.
    BC Vital Statistics Agency. Selected Vital Statistics and Health Status Indicators. Drug-Induced Deaths by Age and Gender. 2000.Google Scholar
  5. 5.
    O’Shaughnessy MV, Montaner JS, Strathdee S, Schechter MT. Deadly public policy. Int Conf AIDS. 1998;12:982.Google Scholar
  6. 6.
    Tyndall MW, Currie S, Spittal P, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17:887–893.PubMedCrossRefGoogle Scholar
  7. 7.
    Wood E, Tyndall MW, Spittal PM, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? CMAJ. 2001;165:405–410.PubMedCentralPubMedGoogle Scholar
  8. 8.
    Kerr TH, Wood E, Palepu A, Wilson D, Schechter MT, Tyndall MW. Responding to explosive HIV epidemics driven by frequent cocaine injection: is there a role for safer injecting facilities? J Drug Issues. 2003;33:579–608.CrossRefGoogle Scholar
  9. 9.
    Dolan K, Kimber J, Fry C, Fitzgerald J, McDonald D, Trautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Rev. 2000;19:337–346.CrossRefGoogle Scholar
  10. 10.
    Hedrich D. European Report on Drug Consumption Rooms: European Monitoring Centre for Drugs and Drug Addiction. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction; 2004.Google Scholar
  11. 11.
    Bundesministerium fur Gesundheit und Soziale Sicherung. Evaluation der Abiet van Drogenkonsumäuen un der Bundesrepulik Deutchland. Baden-Baden, Germany: Nomos; 2003.Google Scholar
  12. 12.
    Ronco C, Spuhler G, Coda P, Schopfer R. Evaluation for alley-rooms I, II, and III in Basel. Soc Prev Med. 1996;41:S58-S68.CrossRefGoogle Scholar
  13. 13.
    Kemmesies U. Final Report: The Open Drug Scene and the Safe Injection Room Offers in Frankfurt am Main. Münster, Germany; Indo; 1999.Google Scholar
  14. 14.
    Wood E, Small W, Li K, Marsh D, Montaner JS, Tyndall MW. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ. 2004;171:731–734.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Kaldor J, Lapsley H, Mattick RP, Weatherburn D, Wilson A. Final Report on the Evaluation of the Sydney Medically Supervised Injecting Centre. Sydney: MSIC Evaluation Committee. 2003.Google Scholar
  16. 16.
    Kimber J, Dolan K, Van Beek I, Hedrich D, Zurhold H. Drug consumption facilities: an update since 2000. Drug Alcohol Rev. 2003;22:227–233.PubMedCrossRefGoogle Scholar
  17. 17.
    CBC News. Real-life Da Vinci leads sweep in Vancouver elections. CBC News. November 18, 2002.Google Scholar
  18. 18.
    Vancouver Sun. 90 arrested in drug sweep: the first five days of a major campaign has produced hundreds of trafficking charges. Vancouver Sun. April 12, 2003:A1.Google Scholar
  19. 19.
    Wood E, Spittal PM, Small W, Kerr T, Li K, Hogg RS, Tyndall MW Montaner JS, Schechter MT. Displacement of Canada’s largest public illicit drug market in response to a police crackdown. CMAJ. 2004 May 11;170:1551–1556.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Maher L, Dixon D. Policing and public health: law enforcement and harm minimization in a street-level drug market. Br J Criminol. 1999;39:488–512.CrossRefGoogle Scholar
  21. 21.
    Aitken C, Moore D, Higgs P, Kelsall J, Kerger M. The impact of a police crackdown on a street drug scene: evidence from the street. Int J Drug Policy. 2002;13:189–198.CrossRefGoogle Scholar
  22. 22.
    Rhodes T, Mikhailova L, Sarang A, et al. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med. 2003;57:39–54.PubMedCrossRefGoogle Scholar
  23. 23.
    Wodak A, Symonds A, Richmond R. The role of civil disobedience in drug policy reform: how an illegal “safer injection room” led to a sanctioned, “medically supervised injection centre”. J Drug Issues. 2003;33:609–624.CrossRefGoogle Scholar
  24. 24.
    Kerr T, Wood E, Small D, Palepu A, Tyndall MW. Potential use of safer injecting facilities among injection drug users in Vancouver’s Downtown Eastside. CMAJ. 2003;169:759–763.PubMedCentralPubMedGoogle Scholar
  25. 25.
    CTV News. Illegal safe injection site opens in Vancouver. CTV News. May 5, 2003.Google Scholar
  26. 26.
    Broadhead RS, Kerr TH, Grund JP, Altice FL. Safer injection facilities in North America: their place in public policy and health initiatives. J Drug Issues. 2002;32:329–355.CrossRefGoogle Scholar
  27. 27.
    Wood E, Kerr T, Small W, Jones J, Schechter MT, Tyndall MW. The impact of police presence on access to needle exchange programs. J Acquir Immune Defic Syndr. 2003;34:116–118.PubMedCrossRefGoogle Scholar
  28. 28.
    Craib KJ, Spittal PM, Wood E, et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ. 2003;168:19–24.PubMedCentralPubMedGoogle Scholar
  29. 29.
    Darke S, Kaye S, Ross J. Geographical injecting locations among injecting drug users in Sydney, Australia. Addiction. 2001;96:241–246.PubMedCrossRefGoogle Scholar
  30. 30.
    Latkin C, Mandell W, Vlahov D, Oziemkowska M, Knowlton A, Celentano D. My place, your place, and no place: behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. Am J Community Psychol. 1994;22:415–430.PubMedCrossRefGoogle Scholar
  31. 31.
    Bruneau J BS, Lamothe F, Vincelette J. What can we learn from chronic, non-infected IDUs: sociodemographic characteristics and factors associated with long-term HIV and HCV seronegativity. Can J Infect Dis. 2001;13:44A.Google Scholar
  32. 32.
    Fry CL. Safer injecting facilities in Vancouver: considering issues beyond potential use. CMAJ. 2003;169:777–778.PubMedCentralPubMedGoogle Scholar
  33. 33.
    Friedman SR, Furst RT, Jose B, et al. Drug scence roles and HIV risk. Addiction. 1998;93:1403–1416.PubMedCrossRefGoogle Scholar
  34. 34.
    Canadian HIV/AIDS Legal Network. Establishing Safe Injection Facilities in Canada: Legal and Ethical Issues. Montreal: Canadian HIV/AIDS Legal Network; 2002.Google Scholar
  35. 35.
    Grund JP, Blanken P, Adriaans NF, Kaplan CD, Barendregt C, Meeuwsen M. Reaching the unreached: targeting hidden IDU populations with clean needles via known user groups. J Psychoactive Drugs. 1992;24:41–47.PubMedCrossRefGoogle Scholar
  36. 36.
    Wood E, Kerr T, Spittal PM, et al. An external evaluation of a peer-run “unsanctioned” syringe exchange program. J Urban Health. 2003;80:455–464.PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Rees V. User groups. Addiction. 1995;90:145.Google Scholar
  38. 38.
    Broadhead RS, Heckathorn DD, Grund JC, Stern LS, Anthony DL. Drug users versus outreach workers in combating AIDS: preliminary results of a peer-driven intervention. J Drug Issues. 1995;25:531–564.Google Scholar
  39. 39.
    Broadhead RS, Heckathorn DD, Weakliem DL, et al. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep. 1998;113:42–57.PubMedCentralPubMedGoogle Scholar
  40. 40.
    Kerr T, Douglas D, Peeace W, Pierre A, Wood E, Responding to an Emergency: Education, Advocacy, and Community Care by a Peer-driven Organization of Drug Users: A Case Study of the Vancouver Area Network of Drug Users (VANDU). Health Canada Hepatitis C Prevention, Support, and Research Program. Ottawa, Canada: Health Canada Hepatitis C Prevention, Support, and Research program 2001.Google Scholar

Copyright information

© Oxford University Press on behalf of the New York Academy of Medicine 2005

Authors and Affiliations

  • Thomas Kerr
    • 1
  • Megan Oleson
    • 3
  • Mark W. Tyndall
    • 1
    • 2
  • Julio Montaner
    • 1
    • 2
  • Evan Wood
    • 1
    • 2
  1. 1.British Columbia Centre for Excellence in HIV/AIDSVancouverCanada
  2. 2.Department of MedicineUniversity of British ColumbiaVancouverCanada
  3. 3.Anti-Poverty CommitteeVancouverCanada

Personalised recommendations